Related Experiment Video

Updated: Jun 12, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Therapeutic strategies in patients with chronic stable coronary artery disease

Michael J Zellweger1, Matthias E Pfisterer

  • 1Division of Cardiology, University Hospital, Petersgraben 4, Basel, Switzerland. mzellweger@uhbs.ch

Cardiovascular Therapeutics
|May 25, 2010
PubMed

Insights

For chronic stable angina, treatment strategies like intense medical therapy versus immediate revascularization show similar outcomes for death or heart attack in selected patients. Risk factor control is crucial for both approaches.

Area of Science:

  • Cardiology
  • Clinical Medicine

Background:

  • Debate exists on optimal treatment for chronic stable angina: intense medical therapy with potential revascularization vs. immediate angiography and revascularization.
  • Two major trials (COURAGE, BARI 2D) evaluated these strategies in specific patient groups.

Purpose of the Study:

  • To review current treatment strategies for chronic stable angina.
  • To discuss the strengths and limitations of medical therapy versus revascularization.
  • To emphasize the role of ischemia assessment in patient risk stratification.

Main Methods:

  • Review of findings from large randomized controlled trials (e.g., COURAGE, BARI 2D).
  • Analysis of treatment strategies including medical management, angiography, and revascularization.
  • Discussion of risk factor control and secondary prevention measures.

Main Results:

  • In selected patients with mild/moderate angina and suitable coronary anatomy, no significant difference in death or myocardial infarction was observed between intense medical therapy and immediate revascularization.
  • Generalizability of these findings to patients with unknown coronary anatomy remains uncertain.

Conclusions:

  • The choice of treatment strategy for chronic stable angina should consider individual patient factors.
  • Documenting the extent of myocardial ischemia is vital for appropriate risk stratification.
  • An evidence-based algorithm is proposed to guide personalized management decisions.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...